Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1CNS 1

Conditions

Breast Neoplasms 558Carcinoma, Non-Small-Cell Lung 517Prostatic Neoplasms 335Colorectal Neoplasms 273Neoplasms 268Multiple Myeloma 267Leukemia, Myeloid, Acute 224Squamous Cell Carcinoma of Head and Neck 217Lung Neoplasms 210Neoplasm Metastasis 205Carcinoma, Hepatocellular 197Melanoma 175Triple Negative Breast Neoplasms 173Pancreatic Neoplasms 171Recurrence 152Ovarian Neoplasms 152Lymphoma 141Glioblastoma 134Brain Neoplasms 133Sarcoma 130Carcinoma, Renal Cell 129Stomach Neoplasms 125Lymphoma, Large B-Cell, Diffuse 125Leukemia, Lymphocytic, Chronic, B-Cell 125Head and Neck Neoplasms 125Rectal Neoplasms 109Precursor Cell Lymphoblastic Leukemia-Lymphoma 109Myelodysplastic Syndromes 103Uterine Cervical Neoplasms 100Urinary Bladder Neoplasms 100

Interventions

thymoglobulin 1fludarabine 1Rituximab 1Melphalan 1Levetiracetam 1Cyclophosphamide 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Chromosome Aberrations × 1 year × Clear all
NCT05735717 2026-04-06

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
70 enrolled
CNSClassical hematologyLymphoidOther hematologic neoplasm

Chromosome 7, monosomy, Anemia, Refractory, with Excess of Blasts, Chromosome Aberrations, Influenza, Human, Neurofibromatosis 1, Leukemia, Myeloid, Acute, beta-Thalassemia, Neoplasm, Residual, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡